T1	intervention 27 50	Platycodon grandiflorum
T2	eligibility 54 130	patients with early breast cancer receiving anthracycline-based chemotherapy
T3	No-of-participants 1106 1109	120
T4	control 1207 1223	placebo granules
T5	outcome-Measure 1273 1286	heart failure
T6	outcome-Measure 1352 1371	all-cause mortality
T7	outcome-Measure 1373 1386	cardiac death
T8	outcome-Measure 1388 1420	electrocardiogram (ECG) findings
T9	outcome-Measure 1422 1457	left ventricular diastolic function
T10	outcome-Measure 1459 1487	longitudinal systolic strain
T11	outcome-Measure 1492 1502	velocities
